Skip to content
10-Q

Quarterly Report

Amarantus Bioscience Holdings, Inc.

0001213900-16-013942

← back to feed
Filed
Jun 1, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 25, 2016 68.27M sh
Cash And Equivalents Q1 2016 · Mar 31, 2016 $100K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $176K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $109K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $214K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$25.83M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$8.69M
Stockholders Equity Q1 2016 · Jul 31, 2015 $3.41M
Stockholders Equity Q1 2016 · Jul 3, 2015 $3.41M
Stockholders Equity Q1 2016 · Jun 30, 2015 $3.41M
Stockholders Equity restated Q1 2016 · Mar 31, 2015 $3.63M
Current Liabilities Q1 2016 · Mar 31, 2016 $15.83M
Current Liabilities Q1 2016 · Dec 31, 2015 $16.11M
Total Liabilities Q1 2016 · Mar 31, 2016 $16.94M
Total Liabilities Q1 2016 · Dec 31, 2015 $17.22M
Current Assets Q1 2016 · Mar 31, 2016 $942K
Current Assets Q1 2016 · Dec 31, 2015 $743K
Total Assets Q1 2016 · Mar 31, 2016 $11.87M
Total Assets Q1 2016 · Dec 31, 2015 $11.69M
Sga Expense Q1 2016 · Mar 31, 2016 $1.3M
Sga Expense Q1 2016 · Mar 31, 2015 $4.06M
Rd Expense Q1 2016 · Mar 31, 2016 $1.36M
Rd Expense Q1 2016 · Mar 31, 2015 $2.48M
Net Income Q1 2016 · Mar 31, 2016 −$1.58M
Net Income Q1 2016 · Mar 31, 2015 −$6.58M
Operating Income Q1 2016 · Mar 31, 2016 −$2.65M
Operating Income Q1 2016 · Mar 31, 2015 −$6.54M